BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33915649)

  • 1. [Detection of circulating tumor cells with chromosomes 7 and 8 polysomy in non-small cell lung cancer and its correlation with epidermal growth factor receptor mutations in cancer tissue].
    Jiang XR; Lu J; Gu YJ; Li YL; Zhao SL; Jin ML
    Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):447-452. PubMed ID: 33915649
    [No Abstract]   [Full Text] [Related]  

  • 2. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
    Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S
    Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study.
    Ding PN; Becker TM; Bray VJ; Chua W; Ma YF; Lynch D; Po J; Luk AWS; Caixeiro N; de Souza P; Roberts TL
    Lung Cancer; 2019 Aug; 134():187-193. PubMed ID: 31319980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 5. Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Jiang T; Zhao J; Zhao C; Li X; Shen J; Zhou J; Ren S; Su C; Zhou C; O'Brien M
    Clin Lung Cancer; 2019 Mar; 20(2):124-133.e2. PubMed ID: 30587399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
    Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis.
    Liu Y; Xing Z; Zhan P; Liu H; Ye W; Lv T; Song Y
    Medicine (Baltimore); 2016 Nov; 95(47):e5115. PubMed ID: 27893656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.
    Lindsay CR; Faugeroux V; Michiels S; Pailler E; Facchinetti F; Ou D; Bluthgen MV; Pannet C; Ngo-Camus M; Bescher G; Caramella C; Billiot F; Remon J; Planchard D; Soria JC; Besse B; Farace F
    Ann Oncol; 2017 Jul; 28(7):1523-1531. PubMed ID: 28633480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma].
    Cao Z; Wang J; Qin N; Li K; Lv J; Wang J; Yang X; Li X; Zhang H; Zhang Q; Long H; Shu C; Ma L; Zhang S
    Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):84-90. PubMed ID: 32093452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
    He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres.
    Wang SG; Zhang B; Li CG; Zhu JQ; Sun BS; Wang CL
    Thorac Cancer; 2020 Oct; 11(10):2887-2895. PubMed ID: 32856417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of EGFR mutation in CTCs based on a double spiral microfluidic chip and the real-time RPA method.
    Li WM; Ren XD; Jiang YZ; Su N; Li BW; Sun XG; Li RX; Lu WP; Deng SL; Li J; Li MX; Huang Q
    Anal Bioanal Chem; 2023 Jul; 415(17):3535-3547. PubMed ID: 37254002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer.
    Zhang Q; Nong J; Wang J; Yan Z; Yi L; Gao X; Liu Z; Zhang H; Zhang S
    Oncol Lett; 2019 Apr; 17(4):3799-3807. PubMed ID: 30881500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.
    Buckingham LE; Coon JS; Morrison LE; Jacobson KK; Jewell SS; Kaiser KA; Mauer AM; Muzzafar T; Polowy C; Basu S; Gale M; Villaflor VM; Bonomi P
    J Thorac Oncol; 2007 May; 2(5):414-22. PubMed ID: 17473657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Clinical Profile of EGFR Mutation In Non- Small-Cell Lung Carcinoma Patients in Southwest China.
    Zhou J; Song XB; He H; Zhou Y; Lu XJ; Ying BW
    Asian Pac J Cancer Prev; 2016; 17(3):965-71. PubMed ID: 27039821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer.
    Hsu CL; Tsai TH; Huang CK; Yang CY; Liao WY; Ho CC; Ruan SY; Chen KY; Shih JY; Yang PC
    Lung Cancer; 2021 Jun; 156():50-58. PubMed ID: 33894494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer.
    Wang J; Sun N; Lee YT; Ni Y; Koochekpour R; Zhu Y; Tseng HR; Wang S; Jiang L; Zhu H
    J Mater Chem B; 2020 Jul; 8(26):5636-5644. PubMed ID: 32525199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating
    Li SH; Wu MH; Wang HM; Hsu PC; Fang YF; Wang CL; Chu HC; Lin HC; Lee LY; Wu CY; Yang CT; Chen JS; Hsieh JC
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142574
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer.
    Ma M; Shi C; Qian J; Teng J; Zhong H; Han B
    Gene; 2016 Oct; 591(1):58-64. PubMed ID: 27370697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.